Clinical Trial Update: Post Marketing Observational Study (PMOS) to Assess Quality of Life in Swedish Hidradenitis Suppurativa (HS) Patients

View source ↗

Summary

Post-marketing observational study assessing quality of life in Swedish patients with hidradenitis suppurativa completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Snippet

Sponsor: AbbVie | Conditions: Hidradenitis Suppurativa | Status: COMPLETED | Results posted: 2019-08-09